Joshua R. Disbrow
2023 - AYTU BIOPHARMA
In 2023, Joshua R. Disbrow earned a total compensation of $708K as Chairman and Chief Executive Officer since December at AYTU BIOPHARMA, a 20% increase compared to previous year.
Compensation breakdown
| Bonus | $118,000 |
|---|---|
| Salary | $590,000 |
| Total | $708,000 |
Disbrow received $590K in salary, accounting for 83% of the total pay in 2023.
Disbrow also received $118K in bonus.
Rankings
In 2023, Joshua R. Disbrow's compensation ranked 1,586th out of 2,918 executives tracked by ExecPay. In other words, Disbrow earned more than 45.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,586 out of 2,918 | 46th |
Division Manufacturing | 933 out of 1,608 | 42nd |
Major group Chemicals And Allied Products | 597 out of 901 | 34th |
Industry group Drugs | 581 out of 864 | 33rd |
Industry Pharmaceutical Preparations | 411 out of 622 | 34th |
Source: SEC filing on May 10, 2024.
Disbrow's colleagues
We found two more compensation records of executives who worked with Joshua R. Disbrow at AYTU BIOPHARMA in 2023.
News
AYTU BIOPHARMA CEO Joshua Disbrow's 2023 pay rises 20% to $708K
May 10, 2024
AYTU BIOPHARMA CEO Joshua Disbrow's 2021 pay jumps 291% to $6.2M
April 7, 2022
AYTU BIOPHARMA CEO Joshua Disbrow's 2020 pay jumps 52% to $1.6M
April 16, 2021
AYTU BIOPHARMA CEO Joshua Disbrow's 2019 pay jumps 72% to $1M
March 5, 2020
AYTU BIOPHARMA CEO Joshua Disbrow's 2018 pay falls 42% to $606K
February 25, 2019